Daiichi Sankyo Says NTK Appeals Tokyo District Court's 203 Billion Yen Claim Dismissal
MT Newswires Live12:25
Daiichi Sankyo (TYO:4568) said that Northern TK Venture (NTK), an indirect wholly-owned subsidiary of Malaysia's IHH Healthcare (KLSE:IHH), has appealed the Tokyo District Court ruling that dismissed all of its claims against Daiichi Sankyo.
The Japan-based pharmaceutical company said that the appeal filed with the Tokyo High Court on Sept. 24 seeks 203.3 billion yen in damages and other claims, according to a Tokyo bourse filing on Monday.
The company said that the Tokyo District Court dismissed NTK's claims on Sept. 10, and it considers the order fair and appropriate.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.